• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

细胞培养中连续的流感病毒生产会显示出缺陷干扰颗粒的周期性积累。

Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.

机构信息

Bioprocess Engineering, Max Planck Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.

出版信息

PLoS One. 2013 Sep 5;8(9):e72288. doi: 10.1371/journal.pone.0072288. eCollection 2013.

DOI:10.1371/journal.pone.0072288
PMID:24039749
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3764112/
Abstract

Influenza viruses are a major public health burden during seasonal epidemics and a continuous threat due to their potential to cause pandemics. Annual vaccination provides the best protection against the contagious respiratory illness caused by influenza viruses. However, the current production capacities for influenza vaccines are insufficient to meet the increasing demands. We explored the possibility to establish a continuous production process for influenza viruses using the duck-derived suspension cell line AGE1.CR. A two-stage bioreactor setup was designed in which cells were cultivated in a first stirred tank reactor where an almost constant cell concentration was maintained. Cells were then constantly fed to a second bioreactor where virus infection and replication took place. Using this two-stage reactor system, it was possible to continuously produce influenza viruses. Surprisingly, virus titers showed a periodic increase and decrease during the run-time of 17 days. These titer fluctuations were caused by the presence of defective interfering particles (DIPs), which we detected by PCR. Mathematical modeling confirmed this observation showing that constant virus titers can only emerge in the absence of DIPs. Even with very low amounts of DIPs in the seed virus and very low rates for de novo DIP generation, defective viruses rapidly accumulate and, therefore, represent a serious challenge for continuous vaccine production. Yet, the continuous replication of influenza virus using a two-stage bioreactor setup is a novel tool to study aspects of viral evolution and the impact of DIPs.

摘要

流感病毒是季节性流行期间的主要公共卫生负担,也是持续存在的威胁,因为它们有可能引发大流行。每年接种疫苗是预防流感病毒引起的传染性呼吸道疾病的最佳方法。然而,目前流感疫苗的生产能力不足以满足不断增长的需求。我们探索了使用源自鸭的悬浮细胞系 AGE1.CR 建立流感病毒连续生产工艺的可能性。设计了一个两阶段生物反应器装置,其中细胞在第一搅拌罐式反应器中培养,在该反应器中保持几乎恒定的细胞浓度。然后,细胞不断被输送到第二个生物反应器中,在那里进行病毒感染和复制。使用这种两阶段反应器系统,可以连续生产流感病毒。令人惊讶的是,在 17 天的运行时间内,病毒滴度呈现周期性的增加和减少。这些滴度波动是由缺陷干扰颗粒(DIP)的存在引起的,我们通过 PCR 检测到了这些颗粒。数学模型证实了这一观察结果,表明只有在不存在 DIP 的情况下才能出现恒定的病毒滴度。即使在种子病毒中存在非常低水平的 DIP 和非常低的从头生成 DIP 速率的情况下,缺陷病毒也会迅速积累,因此对连续疫苗生产构成严重挑战。然而,使用两阶段生物反应器装置连续复制流感病毒是研究病毒进化和 DIP 影响的新工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/59c044655570/pone.0072288.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/fa4d84d6ccc8/pone.0072288.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/00ac78b3c068/pone.0072288.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/1791a166d6cc/pone.0072288.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/c5a4398ba3e4/pone.0072288.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/59c044655570/pone.0072288.g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/fa4d84d6ccc8/pone.0072288.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/00ac78b3c068/pone.0072288.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/1791a166d6cc/pone.0072288.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/c5a4398ba3e4/pone.0072288.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b94/3764112/59c044655570/pone.0072288.g005.jpg

相似文献

1
Continuous influenza virus production in cell culture shows a periodic accumulation of defective interfering particles.细胞培养中连续的流感病毒生产会显示出缺陷干扰颗粒的周期性积累。
PLoS One. 2013 Sep 5;8(9):e72288. doi: 10.1371/journal.pone.0072288. eCollection 2013.
2
Continuous influenza virus production in a tubular bioreactor system provides stable titers and avoids the "von Magnus effect".在管状生物反应器系统中连续生产流感病毒可提供稳定的效价并避免“冯·马格努斯效应”。
PLoS One. 2019 Nov 5;14(11):e0224317. doi: 10.1371/journal.pone.0224317. eCollection 2019.
3
Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral Therapy.甲型流感病毒及其缺陷干扰颗粒的半连续繁殖:分析动态竞争以选择抗病毒治疗候选物。
J Virol. 2021 Nov 23;95(24):e0117421. doi: 10.1128/JVI.01174-21. Epub 2021 Sep 22.
4
Influenza viruses production: Evaluation of a novel avian cell line DuckCelt®-T17.流感病毒的生产:新型禽类细胞系 DuckCelt®-T17 的评估。
Vaccine. 2018 May 24;36(22):3101-3111. doi: 10.1016/j.vaccine.2017.03.102. Epub 2017 May 29.
5
Impact of defective interfering particles on virus replication and antiviral host response in cell culture-based influenza vaccine production.缺陷干扰颗粒对基于细胞培养的流感疫苗生产中病毒复制和抗病毒宿主反应的影响。
Appl Microbiol Biotechnol. 2014 Nov;98(21):8999-9008. doi: 10.1007/s00253-014-5933-y. Epub 2014 Aug 19.
6
Cell culture-based production and in vivo characterization of purely clonal defective interfering influenza virus particles.基于细胞培养的生产和体内鉴定纯克隆缺陷干扰流感病毒颗粒。
BMC Biol. 2021 May 3;19(1):91. doi: 10.1186/s12915-021-01020-5.
7
Defective Interfering Particles of Influenza Virus and Their Characteristics, Impacts, and Use in Vaccines and Antiviral Strategies: A Systematic Review.流感病毒缺陷干扰粒子及其特性、影响及在疫苗和抗病毒策略中的应用:系统评价。
Viruses. 2022 Dec 12;14(12):2773. doi: 10.3390/v14122773.
8
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.悬浮培养鸡胚 AGE1.CR.pIX 细胞生产的减毒流感病毒。
BMC Biotechnol. 2012 Oct 30;12:79. doi: 10.1186/1472-6750-12-79.
9
Production of antiviral "OP7 chimera" defective interfering particles free of infectious virus.生产无感染性病毒的抗病毒“OP7 嵌合体”缺陷干扰颗粒。
Appl Microbiol Biotechnol. 2024 Dec;108(1):97. doi: 10.1007/s00253-023-12959-6. Epub 2024 Jan 13.
10
High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.使用 ATF 系统的杂交补料分批/灌注策略生产高滴度 MVA 和流感 A 病毒。
Appl Microbiol Biotechnol. 2019 Apr;103(7):3025-3035. doi: 10.1007/s00253-019-09694-2. Epub 2019 Feb 23.

引用本文的文献

1
Deletion viral genome diversity among bovine viral diarrhea virus (BVDV) 1a and 1b strains.牛病毒性腹泻病毒(BVDV)1a和1b毒株间缺失型病毒基因组多样性
Virol J. 2025 Jul 14;22(1):237. doi: 10.1186/s12985-025-02773-z.
2
Coronavirus Replication: Genomes, Subgenomic RNAs, and Defective Viral Genomes.冠状病毒复制:基因组、亚基因组RNA和缺陷病毒基因组
Viruses. 2025 May 28;17(6):767. doi: 10.3390/v17060767.
3
Navigating the Purification Process: Maintaining the Integrity of Replication-Competent Enveloped Viruses.探索纯化过程:维持有复制能力的包膜病毒的完整性

本文引用的文献

1
Design requirements for interfering particles to maintain coadaptive stability with HIV-1.干扰粒子与 HIV-1 保持共适应稳定性的设计要求。
J Virol. 2013 Feb;87(4):2081-93. doi: 10.1128/JVI.02741-12. Epub 2012 Dec 5.
2
Live attenuated influenza viruses produced in a suspension process with avian AGE1.CR.pIX cells.悬浮培养鸡胚 AGE1.CR.pIX 细胞生产的减毒流感病毒。
BMC Biotechnol. 2012 Oct 30;12:79. doi: 10.1186/1472-6750-12-79.
3
An overlapping protein-coding region in influenza A virus segment 3 modulates the host response.
Vaccines (Basel). 2025 Apr 23;13(5):444. doi: 10.3390/vaccines13050444.
4
Impact of inactivated vaccine on transmission and evolution of H9N2 avian influenza virus in chickens.灭活疫苗对鸡群中H9N2禽流感病毒传播及进化的影响
NPJ Vaccines. 2025 Apr 4;10(1):67. doi: 10.1038/s41541-025-01115-y.
5
Continuous Production of Influenza VLPs Using IC-BEVS and Multi-Stage Bioreactors.使用昆虫细胞杆状病毒表达系统(IC-BEVS)和多级生物反应器连续生产流感病毒样颗粒(VLPs)
Biotechnol Bioeng. 2025 Apr;122(4):846-857. doi: 10.1002/bit.28925. Epub 2025 Jan 17.
6
Persistent Rhesus Enteric Calicivirus Infection in Recombinant CHO Cells Expressing the Coxsackie and Adenovirus Receptor.在表达柯萨奇病毒和腺病毒受体的重组中国仓鼠卵巢细胞中恒河猴肠道杯状病毒的持续感染
Viruses. 2024 Nov 28;16(12):1849. doi: 10.3390/v16121849.
7
Inno4Vac Workshop Report Part 1: Controlled Human Influenza Virus Infection Model (CHIVIM) Strain Selection and Immune Assays for CHIVIM Studies, November 2021, MHRA, UK.Inno4Vac 研讨会报告第 1 部分:受控人流感病毒感染模型(CHIVIM)的菌株选择和用于 CHIVIM 研究的免疫分析,2021 年 11 月,英国 MHRA。
Influenza Other Respir Viruses. 2024 Nov;18(11):e70014. doi: 10.1111/irv.70014.
8
Innovations in cell culture-based influenza vaccine manufacturing - from static cultures to high cell density cultivations.基于细胞培养的流感疫苗制造创新——从静态培养到高密度培养。
Hum Vaccin Immunother. 2024 Dec 31;20(1):2373521. doi: 10.1080/21645515.2024.2373521. Epub 2024 Jul 15.
9
Influenza A defective viral genomes and non-infectious particles are increased by host PI3K inhibition via anti-cancer drug alpelisib.通过抗癌药物阿哌利西抑制宿主PI3K,可增加甲型流感病毒缺陷病毒基因组和非感染性颗粒。
bioRxiv. 2024 Jul 3:2024.07.03.601932. doi: 10.1101/2024.07.03.601932.
10
Defective viral genomes: advances in understanding their generation, function, and impact on infection outcomes.缺陷型病毒基因组:对其产生、功能及其对感染结果影响的研究进展。
mBio. 2024 May 8;15(5):e0069224. doi: 10.1128/mbio.00692-24. Epub 2024 Apr 3.
甲型流感病毒 3 节段中的重叠编码区调节宿主反应。
Science. 2012 Jul 13;337(6091):199-204. doi: 10.1126/science.1222213. Epub 2012 Jun 28.
4
Modeling the intracellular dynamics of influenza virus replication to understand the control of viral RNA synthesis.建立流感病毒复制的细胞内动力学模型以理解病毒 RNA 合成的控制。
J Virol. 2012 Aug;86(15):7806-17. doi: 10.1128/JVI.00080-12. Epub 2012 May 16.
5
Influenza A viruses: new research developments.甲型流感病毒:新的研究进展。
Nat Rev Microbiol. 2011 Jul 11;9(8):590-603. doi: 10.1038/nrmicro2613.
6
A chemically defined production process for highly attenuated poxviruses.一种用于高减毒痘病毒的化学限定生产工艺。
Biologicals. 2011 Jan;39(1):50-8. doi: 10.1016/j.biologicals.2010.11.005. Epub 2011 Jan 15.
7
Strategies for preventing influenza: future perspectives in influenza vaccine technology.预防流感的策略:流感疫苗技术的未来展望。
Expert Opin Biol Ther. 2011 Jan;11(1):1-4. doi: 10.1517/14712598.2010.539047.
8
Population dynamics of an RNA virus and its defective interfering particles in passage cultures.在传代培养中 RNA 病毒及其缺陷干扰颗粒的种群动态。
Virol J. 2010 Sep 29;7:257. doi: 10.1186/1743-422X-7-257.
9
Defective interfering viruses and their potential as antiviral agents.缺陷干扰病毒及其作为抗病毒剂的潜力。
Rev Med Virol. 2010 Jan;20(1):51-62. doi: 10.1002/rmv.641.
10
Continuous cell lines as a production system for influenza vaccines.连续细胞系作为流感疫苗的生产系统。
Expert Rev Vaccines. 2009 Dec;8(12):1681-92. doi: 10.1586/erv.09.128.